Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Feb 2024

Shen Alan, Arbesman Michelle, Lodha Roshan, Rayman Patricia, Bungo Brandon, Ni Ying, Chan Timothy, Gastman Brian, Ko Jennifer, Diaz-Montero C Marcela, Arbesman Joshua, Funchain Pauline

Abstract excerpt

PURPOSE: Malignant melanoma represents the most lethal skin cancer with germline predispositions thought to comprise 10% to 15% of all melanoma cases. No studies to date examine the immunologic features that may differentiate survival differences between germline pathogenic variant (gPV)-positive patients with melanoma from gPV-negative patients with melanoma. EXPERIMENTAL DESIGN: Adult patients with melanoma and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Germ-Line Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Prognosis

Share to Skin Neoplasms

Share to Tumor Microenvironment

Source

Identifiers

PMID: 38032355
DOI: 10.1158/1078-0432.CCR-23-1964

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma.PMID 38032355Read ↗

Genetic alterations defining human primary melanoma and mechanisms of immune evasionSemantic proximity Read ↗

Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: A valuable model for studying the impact of genetic diversity in melanoma.Semantic proximity Read ↗

Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patientsSemantic proximity Read ↗

Molecular profiling of driver events and tumor-infiltrating lymphocytes in metastatic uveal melanomaSemantic proximity Read ↗

BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating BiomarkersSemantic proximity Read ↗

Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.Semantic proximity Read ↗

Germline variants predictive of tumor mutational burden and immune checkpoint inhibitor efficacySemantic proximity Read ↗

Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in MelanomaSemantic proximity Read ↗

The Immunogenetics of Melanoma.Semantic proximity Read ↗

Translating genetics into tissue: inflammatory cytokine-producing TAMs and PD-L1 tumor expression as poor prognosis factors in cutaneous melanomaSemantic proximity Read ↗

Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypes.Semantic proximity Read ↗

Higher polygenic risk for melanoma is associated with improved survivalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.